Annual report pursuant to Section 13 and 15(d)

Note 7 - Stockholders' Equity - Summary of Stock Option Activity (Details)

v3.24.1
Note 7 - Stockholders' Equity - Summary of Stock Option Activity (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Outstanding, options (in shares) 1,685,000 0 0
Outstanding, weighted average exercise price (in dollars per share) $ 1.14 $ 0 $ 0
Outstanding, aggregate intrinsic value $ 0 $ 0 $ 0
Granted, options (in shares) 1,685,000    
Granted, weighted average exercise price (in dollars per share) $ 1.14    
Outstanding, remaining term (Year) 9 years 6 months    
Vested and Exercisable as of December 31, 2023 (in shares) 262,500    
Vested and Exercisable, weighted average exercise price (in dollars per share) $ 1.14    
Vested and Exercisable, remaining (Year) 9 years 6 months    
Vested and Exercisable, aggregate intrinsic value $ 0